Gene Expression Changes in the Hearts of Fetuses with Down Syndrome
Author Information
Author(s): Conti Anna, Fabbrini Floriana, D'Agostino Paola, Negri Rosa, Greco Dario, Genesio Rita, D'Armiento Maria, Olla Carlo, Paladini Dario, Zannini Mariastella, Nitsch Lucio
Primary Institution: University Federico II, Napoli, Italy
Hypothesis
How does the upregulation of Hsa21 genes influence the expression of genes on other chromosomes in the fetal heart?
Conclusion
The study found that Hsa21 gene upregulation leads to dysregulation of mitochondrial and extracellular matrix genes in the hearts of fetuses with Down syndrome.
Supporting Evidence
- Approximately half of the 15,000 genes examined were expressed in the heart at 18-22 weeks of gestation.
- Hsa21 gene expression was globally upregulated 1.5 fold in trisomic samples.
- Functional analysis revealed downregulation of mitochondrial genes and upregulation of extracellular matrix genes.
- There were no significant differences between trisomic fetuses with and without heart defects.
Takeaway
This study looked at the hearts of babies with Down syndrome and found that some genes are turned up too high, which might cause heart problems.
Methodology
The study used DNA microarray technology to analyze gene expression in heart tissues from fetuses with and without Hsa21 trisomy.
Limitations
The study's findings may be limited by the small sample size and the specific gestational age of the fetuses analyzed.
Participant Demographics
The study included 10 fetuses with Hsa21 trisomy and 5 control euploid fetuses, aged 18-22 weeks of gestation.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website